The impact of a patent on a company's stock price can vary from nil to significant. One example of the latter is investor reaction to the announcement last month that Aastrom Biosciences Inc. had been granted an additional patent for its stem cell technology. Wall Street rewarded the company with a $3 bump to $7.75.

A similar swing occurred in July, when the company announced